A Double-blind, Placebo-controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder
Phase of Trial: Phase IV
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Vilazodone (Primary)
- Indications Depression; Post-traumatic stress disorders
- Focus Therapeutic Use
- 12 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 18 May 2015 Planned End Date changed from 1 Aug 2015 to 1 Apr 2016, according to to ClinicalTrials.gov record.
- 18 May 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Nov 2015, according to to ClinicalTrials.gov record.